NO20024545L - Fremgangsmåte for behandling av kongestiv hjertefeil - Google Patents

Fremgangsmåte for behandling av kongestiv hjertefeil

Info

Publication number
NO20024545L
NO20024545L NO20024545A NO20024545A NO20024545L NO 20024545 L NO20024545 L NO 20024545L NO 20024545 A NO20024545 A NO 20024545A NO 20024545 A NO20024545 A NO 20024545A NO 20024545 L NO20024545 L NO 20024545L
Authority
NO
Norway
Prior art keywords
heart failure
congestive heart
procedures
treating congestive
chf
Prior art date
Application number
NO20024545A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024545D0 (no
Inventor
Irwin Klein
Kaie Ojamma
Original Assignee
Long Island Jewish Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Long Island Jewish Res Inst filed Critical Long Island Jewish Res Inst
Publication of NO20024545D0 publication Critical patent/NO20024545D0/no
Publication of NO20024545L publication Critical patent/NO20024545L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NO20024545A 2000-03-23 2002-09-23 Fremgangsmåte for behandling av kongestiv hjertefeil NO20024545L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/533,227 US6288117B1 (en) 2000-03-23 2000-03-23 Method for treating congestive heart failure
PCT/US2001/008418 WO2001070218A1 (en) 2000-03-23 2001-03-16 Method for treating congestive heart failure

Publications (2)

Publication Number Publication Date
NO20024545D0 NO20024545D0 (no) 2002-09-23
NO20024545L true NO20024545L (no) 2002-10-29

Family

ID=24125041

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024545A NO20024545L (no) 2000-03-23 2002-09-23 Fremgangsmåte for behandling av kongestiv hjertefeil

Country Status (11)

Country Link
US (1) US6288117B1 (de)
EP (1) EP1292292B1 (de)
JP (1) JP2003527420A (de)
AT (1) ATE486594T1 (de)
AU (2) AU4578501A (de)
CA (1) CA2403674C (de)
DE (1) DE60143390D1 (de)
IL (2) IL151878A0 (de)
NO (1) NO20024545L (de)
NZ (1) NZ522088A (de)
WO (1) WO2001070218A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040156893A1 (en) * 2003-02-11 2004-08-12 Irwin Klein Method for treating hypothyroidism
GB0525461D0 (en) * 2005-12-15 2006-01-25 Archimedes Dev Ltd Pharmaceutical compositions
US10695309B2 (en) 2017-03-31 2020-06-30 Western New England University Sustained-release liothyronine formulations, method of preparation and method of use thereof
CN111632155B (zh) * 2020-06-01 2023-01-24 西南大学 丝胶-钆pH响应性靶向肿瘤核磁共振造影剂的制备方法
CN121868277A (zh) * 2026-03-18 2026-04-17 广东医科大学附属第二医院 Slco5a1在制备用于治疗和/或预防心力衰竭药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3689669A (en) * 1970-10-09 1972-09-05 Univ Of North Carolina The Antidepressant method and composition
US5158978A (en) 1990-02-05 1992-10-27 British Technology Group (U.S.A.) Thyroid hormone treatment of acute cardiovascular compromise
ES2115638T3 (es) * 1991-12-30 1998-07-01 Akzo Nobel Nv Composicion tiroactiva de liberacion controlada.

Also Published As

Publication number Publication date
WO2001070218A1 (en) 2001-09-27
IL151878A (en) 2008-08-07
ATE486594T1 (de) 2010-11-15
NO20024545D0 (no) 2002-09-23
US6288117B1 (en) 2001-09-11
NZ522088A (en) 2004-07-30
JP2003527420A (ja) 2003-09-16
CA2403674A1 (en) 2001-09-27
CA2403674C (en) 2010-06-08
AU2001245785B2 (en) 2005-05-19
EP1292292A1 (de) 2003-03-19
EP1292292A4 (de) 2006-02-01
AU4578501A (en) 2001-10-03
DE60143390D1 (de) 2010-12-16
IL151878A0 (en) 2003-04-10
EP1292292B1 (de) 2010-11-03

Similar Documents

Publication Publication Date Title
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
MXPA03006855A (es) Metodo para tratar insuficiencia cardiaca cronica y/o niveles elevados de colesterol, utilizando acido 3,5-diyodotiropropionico, y metodo para su preparacion.
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
NO20050204L (no) Kombinasjoner av legemidler for behandling av neoplasmer
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
DK1365762T3 (da) Fremgangsmåde til forögelse af leptinniveauer under anvendelse af nicotinsyreforbindelser
ATE291433T1 (de) Extrakte von mutterkraut (tanacetum parthenium) gegen entzündliche erkrankungen
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
WO2003079979A3 (en) Method for treating congestive heart failure
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
AU3831301A (en) Method for treating ocular pain
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
SE0104248D0 (sv) Method of treatment
ATE422357T1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
DE60327557D1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
NO20021035D0 (no) Fremgangsmåter for anvendelse av rasktvirkende selektive serotonin gjenopptakningsinhibitorer for behandling av seksuelldysfunksjon
DK1458393T3 (da) Substituerede diketopiperaziner som oxytocinantagonister
PT1631275E (pt) Tratamento e prevenção da cicatrização excessiva com 4-hidroxi-tamoxifeno
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
EA199800864A1 (ru) Способ лечения при боли, вызванной мигренью
NO20024545D0 (no) Fremgangsmåte for behandling av kongestiv hjertefeil
DK1237562T3 (da) Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme
SE0004101D0 (sv) New use
DE69924979D1 (de) Behandlung von chronischen schmerzen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application